Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-11-01. On CanQuery you can follow the original downloads. Files are available in English and French.
Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated to reflect that an ultrasound is no longer required before the drug is prescribed. Mifegymiso is a combination product containing two drugs (mifepristone and misoprostol) that are taken in sequence for the medical termination of a pregnancy.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-11-01
Data overview
- Formats
- HTML
- File languages
- English, French